PMC:7388103 / 7806-9076
Annnotations
LitCovid_Glycan-Motif-Structure
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T33 | 81-88 | https://glytoucan.org/Structures/Glycans/G00021MO | denotes | heparin |
T34 | 81-88 | https://glytoucan.org/Structures/Glycans/G54161DR | denotes | heparin |
T35 | 100-107 | https://glytoucan.org/Structures/Glycans/G00021MO | denotes | heparin |
T36 | 100-107 | https://glytoucan.org/Structures/Glycans/G54161DR | denotes | heparin |
T37 | 140-147 | https://glytoucan.org/Structures/Glycans/G00021MO | denotes | heparin |
T38 | 140-147 | https://glytoucan.org/Structures/Glycans/G54161DR | denotes | heparin |
LitCovid-PD-FMA-UBERON
Id | Subject | Object | Predicate | Lexical cue | fma_id |
---|---|---|---|---|---|
T58 | 81-88 | Body_part | denotes | heparin | http://purl.org/sig/ont/fma/fma82839 |
T59 | 100-107 | Body_part | denotes | heparin | http://purl.org/sig/ont/fma/fma82839 |
T60 | 140-147 | Body_part | denotes | heparin | http://purl.org/sig/ont/fma/fma82839 |
T61 | 1158-1162 | Body_part | denotes | limb | http://purl.org/sig/ont/fma/fma7182 |
LitCovid-PD-UBERON
Id | Subject | Object | Predicate | Lexical cue | uberon_id |
---|---|---|---|---|---|
T12 | 1158-1162 | Body_part | denotes | limb | http://purl.obolibrary.org/obo/UBERON_0002101 |
LitCovid-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T91 | 66-69 | Disease | denotes | HIT | http://purl.obolibrary.org/obo/MONDO_0018048 |
T92 | 525-528 | Disease | denotes | HIT | http://purl.obolibrary.org/obo/MONDO_0018048 |
T93 | 572-575 | Disease | denotes | HIT | http://purl.obolibrary.org/obo/MONDO_0018048 |
T94 | 653-663 | Disease | denotes | thrombosis | http://purl.obolibrary.org/obo/MONDO_0000831 |
T95 | 924-948 | Disease | denotes | consumptive coagulopathy | http://purl.obolibrary.org/obo/MONDO_0001243 |
T96 | 936-948 | Disease | denotes | coagulopathy | http://purl.obolibrary.org/obo/MONDO_0001531 |
T97 | 969-977 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T98 | 1088-1093 | Disease | denotes | lupus | http://purl.obolibrary.org/obo/MONDO_0004670 |
T99 | 1143-1153 | Disease | denotes | thrombosis | http://purl.obolibrary.org/obo/MONDO_0000831 |
T100 | 1263-1266 | Disease | denotes | HIT | http://purl.obolibrary.org/obo/MONDO_0018048 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T84 | 134-135 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T85 | 349-350 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T86 | 393-394 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T87 | 434-435 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T88 | 704-705 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | A |
T89 | 1055-1056 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T90 | 1158-1162 | http://www.ebi.ac.uk/efo/EFO_0000876 | denotes | limb |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T41 | 81-88 | Chemical | denotes | heparin | http://purl.obolibrary.org/obo/CHEBI_28304 |
T42 | 100-107 | Chemical | denotes | heparin | http://purl.obolibrary.org/obo/CHEBI_28304 |
T43 | 140-147 | Chemical | denotes | heparin | http://purl.obolibrary.org/obo/CHEBI_28304 |
T44 | 148-161 | Chemical | denotes | anticoagulant | http://purl.obolibrary.org/obo/CHEBI_50249 |
T45 | 295-305 | Chemical | denotes | argatroban | http://purl.obolibrary.org/obo/CHEBI_48720 |
T46 | 307-318 | Chemical | denotes | bivalirudin | http://purl.obolibrary.org/obo/CHEBI_59173 |
T47 | 332-344 | Chemical | denotes | fondaparinux | http://purl.obolibrary.org/obo/CHEBI_61033 |
T48 | 363-376 | Chemical | denotes | anticoagulant | http://purl.obolibrary.org/obo/CHEBI_50249 |
T49 | 406-415 | Chemical | denotes | inhibitor | http://purl.obolibrary.org/obo/CHEBI_35222 |
T50 | 577-587 | Chemical | denotes | argatroban | http://purl.obolibrary.org/obo/CHEBI_48720 |
T51 | 725-735 | Chemical | denotes | argatroban | http://purl.obolibrary.org/obo/CHEBI_48720 |
T52 | 914-922 | Chemical | denotes | warfarin | http://purl.obolibrary.org/obo/CHEBI_10033 |
T53 | 1069-1078 | Chemical | denotes | inhibitor | http://purl.obolibrary.org/obo/CHEBI_35222 |
T54 | 1094-1107 | Chemical | denotes | anticoagulant | http://purl.obolibrary.org/obo/CHEBI_50249 |
T55 | 1201-1211 | Chemical | denotes | argatroban | http://purl.obolibrary.org/obo/CHEBI_48720 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T73 | 0-479 | Sentence | denotes | The first step in the management of highly suspected or confirmed HIT is to stop heparin (including heparin flushes), and to initiate a non-heparin anticoagulant, to prevent thrombotic events, in the setting of ongoing massive thrombin generation.4 Available options for anticoagulation include argatroban, bivalirudin, danaparoid, fondaparinux, or a direct oral anticoagulant.6 Argatroban is a reversible inhibitor of thrombin5 with a short half-life and is not renally cleared. |
T74 | 480-1168 | Sentence | denotes | It is commonly used in the United States for HIT.4 In 2 multicenter trials of patients with HIT, argatroban resulted in reduced composite endpoint of death, amputation, and thrombosis, when compared with historic controls.5 A major concern with argatroban is potential under-anticoagulation in patients with elevated partial thromboplastin time, secondary to additional coagulopathies (hepatic dysfunction, prior anticoagulation with warfarin, consumptive coagulopathy, and more recently, COVID-19).4 Partial thromboplastin time confounding may also occur in the presence of a nonspecific inhibitor (such as lupus anticoagulant).8 This would increase the risk of thrombosis and limb loss. |
T75 | 1169-1270 | Sentence | denotes | Data supporting the efficacy of argatroban is limited to patients with suspected or confirmed HIT.8,9 |
LitCovid-PD-HP
Id | Subject | Object | Predicate | Lexical cue | hp_id |
---|---|---|---|---|---|
T65 | 66-69 | Phenotype | denotes | HIT | http://purl.obolibrary.org/obo/HP_0011874 |
T66 | 525-528 | Phenotype | denotes | HIT | http://purl.obolibrary.org/obo/HP_0011874 |
T67 | 572-575 | Phenotype | denotes | HIT | http://purl.obolibrary.org/obo/HP_0011874 |
T68 | 850-864 | Phenotype | denotes | coagulopathies | http://purl.obolibrary.org/obo/HP_0003256 |
T69 | 936-948 | Phenotype | denotes | coagulopathy | http://purl.obolibrary.org/obo/HP_0003256 |
T70 | 1088-1107 | Phenotype | denotes | lupus anticoagulant | http://purl.obolibrary.org/obo/HP_0025343 |
T71 | 1263-1266 | Phenotype | denotes | HIT | http://purl.obolibrary.org/obo/HP_0011874 |
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
347 | 227-235 | Gene | denotes | thrombin | Gene:2147 |
348 | 419-427 | Gene | denotes | thrombin | Gene:2147 |
349 | 558-566 | Species | denotes | patients | Tax:9606 |
350 | 774-782 | Species | denotes | patients | Tax:9606 |
351 | 1226-1234 | Species | denotes | patients | Tax:9606 |
352 | 81-88 | Chemical | denotes | heparin | MESH:D006493 |
353 | 100-107 | Chemical | denotes | heparin | MESH:D006493 |
354 | 140-147 | Chemical | denotes | heparin | MESH:D006493 |
355 | 295-305 | Chemical | denotes | argatroban | MESH:C031942 |
356 | 320-330 | Chemical | denotes | danaparoid | MESH:C035838 |
357 | 332-344 | Chemical | denotes | fondaparinux | MESH:D000077425 |
358 | 379-389 | Chemical | denotes | Argatroban | MESH:C031942 |
359 | 577-587 | Chemical | denotes | argatroban | MESH:C031942 |
360 | 725-735 | Chemical | denotes | argatroban | MESH:C031942 |
361 | 914-922 | Chemical | denotes | warfarin | MESH:D014859 |
362 | 1201-1211 | Chemical | denotes | argatroban | MESH:C031942 |
363 | 66-69 | Disease | denotes | HIT | MESH:D013921 |
364 | 174-184 | Disease | denotes | thrombotic | MESH:D013927 |
365 | 525-528 | Disease | denotes | HIT | MESH:D013921 |
366 | 572-575 | Disease | denotes | HIT | MESH:D013921 |
367 | 630-635 | Disease | denotes | death | MESH:D003643 |
368 | 653-663 | Disease | denotes | thrombosis | MESH:D013927 |
369 | 850-864 | Disease | denotes | coagulopathies | MESH:D001778 |
370 | 866-885 | Disease | denotes | hepatic dysfunction | MESH:D008107 |
371 | 924-948 | Disease | denotes | consumptive coagulopathy | MESH:D004211 |
372 | 969-977 | Disease | denotes | COVID-19 | MESH:C000657245 |
373 | 1143-1153 | Disease | denotes | thrombosis | MESH:D013927 |
374 | 1158-1167 | Disease | denotes | limb loss | MESH:D017880 |
375 | 1263-1266 | Disease | denotes | HIT | MESH:D013921 |
2_test
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
32720827-30482768-61488857 | 377-378 | 30482768 | denotes | 6 |
32720827-28416511-61488858 | 427-428 | 28416511 | denotes | 5 |
32720827-28416511-61488859 | 702-703 | 28416511 | denotes | 5 |
32720827-25590528-61488860 | 1109-1110 | 25590528 | denotes | 8 |
32720827-25590528-61488861 | 1267-1268 | 25590528 | denotes | 8 |
32720827-21264902-61488862 | 1269-1270 | 21264902 | denotes | 9 |